Vytas A. Bankaitis, PhD
Distinguished Professor, E.L. Wehner-Welch Foundation Chair in Chemistry
Contact
Cell Biology and Genetics
116A Reynolds Medical Building
College Station,
TX
77843-1114
vytas@tamu.edu
Phone: 979.436.0757
Fax: 979.847.9481
Biography
Bankaitis' laboratory is interested in the regulatory interfaces between novel lipid-mediated signal transduction pathways and important cellular functions. The focus of his work is the phosphatidylinositol/phosphatidylcholine transfer proteins (PITPs), a ubiquitous but enigmatic class of proteins. Ongoing projects in the laboratory derive from a multidisciplinary approach that encompasses biochemical characterization of novel members of the metazoan PITP family, and the application of genetic, molecular and biophysical approaches to detailed structural and functional analyses of PITPs.Education and Training
- Edinboro University, BS, 1978
- Clemson University, MS, 1980
- University of North Carolina, PhD, 1984
- California Institute of Technology, Postdoctoral, 1986
Research Interests
- Lipid-mediated Signal Transduction: Bankaitis' laboratory is interested in the regulatory interfaces between novel lipid-mediated signal transduction pathways and important cellular functions. The focus of his work is the phosphatidylinositol/phosphatidylcholine transfer proteins (PITPs), a ubiquitous but enigmatic class of proteins. Ongoing projects in the laboratory derive from a multidisciplinary approach that encompasses biochemical characterization of novel members of the metazoan PITP family, and the application of genetic, molecular and biophysical approaches to detailed structural and functional analyses of PITPs. The laboratory breaks down into two groups: a group that studies the mechanism of function of fungal and plant PITPs, and a group that generates knockout mice and analyzes the function of specific PITP isoforms in the mammal. His collective evidence indicates that PITPs coordinate key interfaces of lipid-driven metabolic reactions and intracellular signaling pathways in both yeast and mammals. Inappropriate regulation of these interfaces compromises membrane trafficking events, growth factor receptor function, cell growth control, and regulation of key developmental pathways. Because defects in any one of these pathways define recognized cancer-potentiating mechanisms, PITPs represent essentially unstudied regulators whose dysfunction is likely to influence the activities of cellular processes required for cellular homeostasis. Of additional interest is the recent finding that one of his PITP-deficient mouse lines potentially provides a unique model for chylomicron retention disease, diabetes and brain inflammatory disease. Relevant approaches that the laboratory employs include: molecular biology, protein and lipid biochemistry, confocal and electron microscopy, mouse gene knockout technology, and classical and molecular genetics. The lab is also developing new approaches for rapidly and confidently identifying the first small molecule inhibitors directed against target PITPs of interest, and other key enzymes of lipid metabolism, for use as tool compounds and as lead compounds for development of next-generation anti-fungal drugs.
- Key discoveries made by the lab include:• The first demonstration that lipids are integral components of the strategy by which the core membrane trafficking machinery is regulated.• The first identification of an in vivo function for a phospholipid-transfer protein via the determination that one of the yeast sec gene products (i.e. Sec14) is a PITP.• The 'bypass Sec14' studies that are widely credited as representing seminal advances in the membrane trafficking field on the basis of providing the first experimental evidence that lipid metabolism is intimately connected to membrane trafficking reactions. Previous to that work, an active role for lipids was ignored in discussions of how transport vesicles bud, dock and fuse.• Solution of an apo-Sec14 crystal structure that provided the first description of a novel structural fold termed the Sec14-domain or, alternatively, the CRAL-TRIO domain.• The first demonstration that Kes1, one of the enigmatic oxysterol binding proteins, regulates TGN membrane trafficking with the Pik1 PtdIns 4-OH kinase a likely target for control.• The first isolation of headgroup-specific Class 1 PITP PL-binding mutants and the first analysis of what role individual PL-binding activities play in Class 1 PITP function.• The first creation of a mammalian model for PITP nullizygosity and the demonstration that PtdIns binding is an essential functional property of a metazoan PITP.• Structural, biochemical and genetic studies that demonstrate PITPs both potentiate and determine outcomes of PtdIns kinase action, a particularly interesting and novel mode of signaling control.• Identification and in vivo and in vitro validation of small molecule inhibitors specifically directed against the yeast Sec14. This effort involved assembly of a unique screening platform for identifying SMIs directed against any PITP of the investigator's choice.• Discovery that a specific ORP (Kes1) participates in a novel signaling pathway by integrating endosomal lipid metabolism with TOR signaling and nitrogen sensing.
Awards, Recognition and Service
- 1978-1980: Graduate Student, Department of Microbiology, Clemson University, Clemson, South Carolina. Advisor: Dr. Ellis L. Kline. 1980-1984: Predoctoral Fellow of the Humphrey Foundation, Department of Microbiology and Immunology, The University of North Carolina School of Medicine. Advisor: Dr. Philip J. Bassford Jr. 1984-1986: Postdoctoral Fellow of the Helen Hay Whitney Foundation, Division of Biology, The California Institute of Technology, Pasadena, CA. 1986-1992: Assistant Professor, Department of Microbiology, University of Illinois, Urbana, IL. Head: Dr. Charles G. Miller. 1992-2001: Associate Professor then Professor, Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL. Head: Dr. Richard B. Marchase. 2001-2011: Professor and Chair, Department of Cell & Developmental Biology, The University of North Carolina School of Medicine, Chapel Hill, NC. 2012-Present: E.L. Wehner-Welch Foundation Chair in Chemistry, Department of Molecular & Cellular Medicine, Texas A&M University Naresh K. Vashisht College of Medicine, College Station, TX.
- • Recipient of an NCAA Postgraduate Fellowship - A national award presented to 6 outstanding student-athletes, 1978.• Recipient of the President's Award for the outstanding student research presentation; regional meeting for the Southeastern and South Carolina branches of the American Society for Microbiology, November 1979.• Recipient of a Predoctoral Fellowship of the Humphrey Foundation - awarded to outstanding incoming graduate students at the University of North Carolina, August 1980.• Recipient of a Postdoctoral Fellowship of the Helen Hay Whitney Foundation, January 1984.• Designated an Arnold Beckman Scholar, University of Illinois, 1986.• Member, Cell Biology Advisory Panel, National Science Foundation, 1988-1992.• Member CDF-2 IRG, NIH, 2001-2004.• Chairman CDF-2 and MMBP Initial Review Group, NIH, 2004-2006.• Member, Faculty of 1000, Membrane Trafficking and Sorting Section• Member, Editorial Advisory Board, EMBO Reports, 2012-present.• Vice-Chair -- Gordon Research Conferences -- Signal Transduction Within the Nucleus, 2009.• Chair -- Gordon Research Conferences -- Signal Transduction Within the Nucleus 2011• Member, Program Planning Committee, American Society for Biochemistry and Molecular Biology Annual Meeting, 2011.• Director, Lipid Research Division, American Society for Biochemistry and Molecular Biology, 2013.• Designated Texas A&M University Distinguished Professor, 2016.• Awardee, American Society for Biochemistry and Molecular Biology Avanti Award in Lipid Research, 2019.
- Lipid Research Division Director conferred by American Society for Biochemistry and Molecular Biology - (Rockville, Maryland, United States)
Representative Publications
List of Recent Publications :
- TI Igumenova, VA Bankaitis. BPS2026–An atomistic view of lipid exchange by Sec14-like phosphatidylinositol transfer proteins. Biophysical Journal 125 (4), 297a-298a, 2026
- VA Bankaitis, X Yu, XR Chen, M Lönnfors, TI Igumenova. In vitro methods for measuring lipid binding, transfer and competitive displacement reactions by peripheral membrane proteins. Methods in Enzymology 727, 373-416, 2026
-
VA Bankaitis, D Khan, XR Chen, Y Wang, TI Igumenova. A brief history of phosphatidylinositol transfer proteins: from the backwaters of cell biology to prime time in lipid signaling. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2025
- X Yu, CJ Mousley, VA Bankaitis, P Iyer. A budding yeast-centric view of oxysterol binding protein family function. Advances in Biological Regulation 95, 101061, 2025
- Xiao-Ru Chen, Karuna Dixit, Yuan Yang, Mark I McDermott, Hasan T Imam, Vytas A Bankaitis, Tatyana I Igumenova. A non-catalytic mechanism for Pin1-mediated regulation of Protein Kinase C through a novel bivalent interaction. PROTEIN SCIENCE 33, 56-57, 2024
-
A Pathak, KG Willis, VA Bankaitis, MI McDermott. Mammalian START-like phosphatidylinositol transfer proteins–Physiological perspectives and roles in cancer biology. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2024
-
Z Xie, A Pathak, VA Bankaitis. A pontine-specific axonal niche supports de novo gliomagenesis. bioRxiv, 2024.09. 04.611079, 2024
-
XR Chen, K Dixit, Y Yang, MI McDermott, HT Imam, VA Bankaitis,TI Igumenova A novel bivalent interaction mode underlies a non-catalytic mechanism for Pin1-mediated protein kinase C regulationElife 13, e92884, 2024
- JG ALB JR, J ORDWAY, PJ DETLOFF, VA BANKAITIS. Generation of mouse embryonic stem cells deficient in PITPa protein and targeted chimeric mice. A functional analysis of metazoan phosphatidylinositol transfer proteins., 85, 2024
-
Y Wang, MJO Wakelam, VA Bankaitis, MI McDermott. The wide world of non-mammalian phospholipase D enzymes. Advances in Biological Regulation 91, 101000, 2024
-
KM Pflug, DW Lee, A Tripathi, VA Bankaitis, K Burgess, R Sitcheran. Cyanine dye conjugation enhances crizotinib localization to intracranial tumors, attenuating NF-κB-inducing kinase activity and glioma progression. Molecular Pharmaceutics 20 (12), 6140-6150, 2023
-
A Arabiotorre, VA Bankaitis, A Grabon. Regulation of phosphoinositide metabolism in Apicomplexan parasites. Frontiers in Cell and Developmental Biology 11, 1163574, 2023
-
Yu-Te Yeh, Chandan Sona, Xin Yan, Yunxiao Li, Adrija Pathak, Mark I McDermott, Zhigang Xie, Liangwen Liu, Anoop Arunagiri, Yuting Wang, Amaury Cazenave-Gassiot, Adhideb Ghosh, Ferdinand von Meyenn, Sivarajan Kumarasamy, Sonia M Najjar, Shiqi Jia, Markus R Wenk, Alexis Traynor-Kaplan, Peter Arvan, Sebastian Barg, Vytas A Bankaitis, Matthew N Poy. Restoration of PITPNA in Type 2 diabetic human islets reverses pancreatic beta-cell dysfunction. Nature communications 14 (1), 4250, 2023
-
Xiao-Ru Chen, Lokendra Poudel, Zebin Hong, Philipp Johnen, Sachin Katti, Ashutosh Tripathi, Aaron H Nile, Savana M Green, Danish Khan, Gabriel Schaaf, Fulvia Bono, Vytas A Bankaitis, Tatyana I Igumenova. Mechanisms by which small molecules of diverse chemotypes arrest Sec14 lipid transfer activity. Journal of Biological Chemistry 299 (2), 102861, 2023
- V Bankatis. Phosphatidylinositol-4-phosphate signaling regulates dense granule biogenesis and exocytosis inToxoplasma gondii. bioRxiv (Cold Spring Harbor Laboratory), 2023
-
A Arabiotorre, M Formanowicz, VA Bankaitis, A Grabon. Phosphatidylinositol-4-phosphate signaling regulates dense granule biogenesis and exocytosis in Toxoplasma gondii. bioRxiv, 2023
-
MA Bieniawski, KLP Stevens, CM Witham, RFL Steuart, VA Bankaitis, CJ Mousley. Diverse sphingolipid species harbor different effects on ire1 clustering. International Journal of Molecular Sciences 23 (20), 12130, 2022
-
Xiao-Ru Chen, Lokendra Poudel, Zebin Hong, Philipp Johnen, Sachin S Katti, Ashutosh Tripathi, Aaron H Nile, Savana M Green, Gabriel Schaaf, Fulvia Bono, Vytas A Bankaitis, Tatyana I Igumenova. Mechanisms by Which Small Molecule Inhibitors Arrest Sec14 Phosphatidylinositol Transfer Protein Activity. bioRxiv, 2022.08. 01.502361, 2022
-
Z Xie, VA Bankaitis. Phosphatidylinositol transfer protein/planar cell polarity axis regulates neocortical morphogenesis by supporting interkinetic nuclear migration. Cell reports 39 (9), 2022
-
VA Bankaitis, A Tripathi, XR Chen, TI Igumenova. New strategies for combating fungal infections: Inhibiting inositol lipid signaling by targeting Sec14 phosphatidylinositol transfer proteins. Advances in biological regulation 84, 100891, 2022
-
N Maitra, S Hammer, C Kjerfve, VA Bankaitis, M Polymenis. Translational control of lipogenesis links protein synthesis and phosphoinositide signaling with nuclear division in Saccharomyces cerevisiae. Genetics 220 (1), iyab171, 2022
-
D Khan, AH Nile, A Tripathi, VA Bankaitis. Emerging prospects for combating fungal infections by targeting phosphatidylinositol transfer proteins. International Journal of Molecular Sciences 22 (13), 6754, 2021
-
T Sugiura, H Nakao, K Ikeda, D Khan, AH Nile, VA Bankaitis, M Nakano. Biophysical parameters of the Sec14 phospholipid exchange cycle–Effect of lipid packing in membranes. Biochimica et Biophysica Acta (BBA)-Biomembranes 1863 (1), 183450, 2021
-
Z Xie, VA Bankaitis. Neural stem cell interkinetic nuclear migration is controlled by a phosphatidylinositol transfer protein/non-canonical planar cell polarity signaling axis. bioRxiv, 2020.12. 17.423231, 2020
-
MG Lete, A Tripathi, V Chandran, VA Bankaitis, MI McDermott. Lipid transfer proteins and instructive regulation of lipid kinase activities: Implications for inositol lipid signaling and disease. Advances in biological regulation 78, 100740, 2020
Complete List of Publications:
https://scholar.google.com/citations?hl=en&user=LInsrMEAAAAJ&view_op=list_works&sortby=pubdate